Unknown

Dataset Information

An updated review of SARS-CoV-2 detection methods in the context of a novel coronavirus pandemic.


ABSTRACT: The World Health Organization has reported approximately 430 million confirmed cases of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), worldwide, including nearly 6 million deaths, since its initial appearance in China in 2019. While the number of diagnosed cases continues to increase, the need for technologies that can accurately and rapidly detect SARS-CoV-2 virus infection at early phases continues to grow, and the Federal Drug Administration (FDA) has licensed emergency use authorizations (EUAs) for virtually hundreds of diagnostic tests based on nucleic acid molecules and antigen-antibody serology assays. Among them, the quantitative real-time reverse transcription PCR (qRT-PCR) assay is considered the gold standard for ear

SUBMITTER: Zhang Y 

PROVIDER: S-EPMC9349698 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature